Austrālija - angļu - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - chicken anaemia virus (living, attenuated) strain 26p4 - misc. vaccines or anti sera - chicken anaemia virus (living, attenuated) strain 26p4 vaccine-viral active 0.0 undefined - immunotherapy - chicken progeny - cav disease

Eiropas Savienība - angļu - EMA (European Medicines Agency)

pierre fabre medicament - busulfan - hematopoietic stem cell transplantation - antineoplastic agents - busilvex followed by cyclophosphamide (bucy2) is indicated as conditioning treatment prior to conventional haematopoietic progenitor cell transplantation (hpct) in adult patients when the combination is considered the best available option.busilvex following fludarabine (fb) is indicated as conditioning treatment prior to haematopoietic progenitor cell transplantation (hpct) in adult patients who are candidates for a reduced-intensity conditioning (ric) regimen.busilvex followed by cyclophosphamide (bucy4) or melphalan (bumel) is indicated as conditioning treatment prior to conventional haematopoietic progenitor cell transplantation in paediatric patients.

Eiropas Savienība - angļu - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - busulfan - hematopoietic stem cell transplantation - alkyl sulfonates - busulfan fresenius kabi followed by cyclophosphamide (bucy2) is indicated as conditioning treatment prior to conventional haematopoietic progenitor cell transplantation (hpct) in adult patients when the combination is considered the best available option.busulfan fresenius kabi followed by cyclophosphamide (bucy4) or melphalan (bumel) is indicated as conditioning treatment prior to conventional haematopoietic progenitor cell transplantation in paediatric patients.

Eiropas Savienība - angļu - EMA (European Medicines Agency)

intervet international bv - clostridium-perfringens-type-a alpha toxoid - immunologicals for aves - chicken - for the active immunisation of chickens to provide passive immunisation against necrotic enteritis to their progeny, during the laying period.to reduce mortality and the incidence and severity of lesions caused by clostridium-perfringens-type-a-induced necrotic enteritis. efficacy was demonstrated by challenge of chicks approximately three weeks after hatching.the onset of passive transfer of immunity: 6 weeks following completion of the vaccination procedure.the duration of passive transfer of immunity: 51 weeks following completion of the vaccination procedure.

Eiropas Savienība - angļu - EMA (European Medicines Agency)

intervet international bv - clostridium perfringens type c / escherichia coli f4ab / e. coli f4ac / e. coli f5 / e. coli f6 / e. coli lt - immunologicals - pigs - for the passive immunisation of progeny by active immunisation of sows and gilts to reduce mortality and clinical signs during the first days of life, caused by those escherichia coli strains which express the adhesins f4ab (k88ab), f4ac (k88ac), f5 (k99) or f6 (987p) and caused by clostridium perfringens type c.,

Eiropas Savienība - angļu - EMA (European Medicines Agency)

zoetis belgium sa - live attenuated aujeszky's disease virus - immunologicals - pigs - active immunisation of pigs from the age of 10 weeks to prevent the mortality and clinical signs of aujeszky's disease and to reduce the excretion of aujeszky's disease field virus. passive immunisation of the progeny of vaccinated gilts and sows to reduce mortality and clinical signs of aujeszky's disease and to reduce the excretion of aujeszky's disease field virus.

Eiropas Savienība - angļu - EMA (European Medicines Agency)

adienne s.r.l. s.u. - thiotepa - hematopoietic stem cell transplantation - antineoplastic agents - in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.". it is proposed that tepadina must be prescribed by physicians experienced in conditioning treatment prior to haematopoietic progenitor cell transplantation.

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

rebel distributors corp - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - tramadol hydrochloride 37.5 mg - tramadol hydrochloride and acetaminophen tablets are indicated for the short-term (five days or less) management of acute pain. tramadol hydrochloride and acetaminophen tablets should not be administered to patients who have previously demonstrated hypersensitivity to tramadol, acetaminophen, any other component of this product or opioids. tramadol hydrochloride and acetaminophen is contraindicated in any situation where opioids are contraindicated, including acute intoxication with any of the following: alcohol, hypnotics, narcotics, centrally acting analgesics, opioids or psychotropic drugs. tramadol hydrochloride and acetaminophen may worsen central nervous system and respiratory depression in these patients. abuse tramadol has mu-opioid agonist activity. tramadol hydrochloride and acetaminophen tablets, a tramadol-containing product, can be abused and may be subject to criminal diversion. addiction is a primary, chronic, neurobiologic disease, with genetic, psychosocial, and environmental factors influenc

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

rebel distributors corp. - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j) - tramadol hydrochloride 50 mg - tramadol hydrochloride is indicated for the management of moderate to moderately severe pain in adults. tramadol hydrochloride should not be administered to patients who have previously demonstrated hypersensitivity to tramadol, any other component of this product or opioids. tramadol hydrochloride is contraindicated in any situation where opioids are contraindicated, including acute intoxication with any of the following: alcohol, hypnotics, narcotics, centrally acting analgesics, opioids or psychotropic drugs. tramadol hydrochloride may worsen central nervous system and respiratory depression in these patients. abuse tramadol has mu-opioid agonist activity. tramadol hydrochloride tablets can be abused and may be subject to criminal diversion. addiction is a primary, chronic, neurobiologic disease, with genetic, psychosocial, and environmental factors influencing its development and manifestations. drug addiction is characterized by behaviors that include one or more of the following: impaired control over d

Eiropas Savienība - angļu - EMA (European Medicines Agency)

medac gesellschaft für klinische spezialpräparate mbh - carmustine - hodgkin disease; lymphoma, non-hodgkin - antineoplastic agents - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).